Compremium AG

Compremium AG is a Swiss medical device company focused on developing innovative, non-invasive diagnostic tools for pressure-related conditions. Their mission is to improve patient outcomes through precise and reliable diagnostic solutions, addressing critical unmet needs in healthcare.

Compremium

Compremium AG

Worbstrasse 46, 3074 Muri b. Bern, Switzerland

https://www.compremium.ch/

v.baumann@compremium.ch

What We Do

CPMX1

A new quantitative and intuitive method for diagnosing musculoskeletal conditions, FDA cleared for clinical use.

CPMX2

A new method to directly measure pressure for diagnosing vascular conditions, currently for investigational purposes only.

Digital Health Technologies

Medical Decision Assistance

Infectious Diseases

Point of Care or rapid Diagnostics

Diagnostics

Imaging (CT, MRI, Ultrasound, X-ray)

Key People

Vincent Baumann

Chief Executive Officer

Ulrich Baumann, MD

Chief Medical Officer

Francois Monory

OPEX-Advisor & Board Member

Aswin Bhuvanendran

Chief Commercial Officer

Patrick Roth

Chief Operations Officer

Robin Demesmaeker

Chief Technology Officer

News & Updates

Compremium captures award at prestigious pediatric medical device competition

Compremium was awarded a $50,000 grant in the 'Make Your Medical Device Pitch for Kids!' competition, focusing on improving care for children with heart conditions.

ISO 13485 Certification: A commitment to quality and innovation

Compremium has successfully obtained the ISO 13485:2016 certification for its quality management system, reflecting its commitment to high standards in medical device design and development.

CPMX1 is MIL-STD 810H compliant and ready for duty

Compremium has achieved MIL-STD 810H compliance for the CPMX1 device, ensuring its capability to operate in austere environments.